642 related articles for article (PubMed ID: 34989964)
1. Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review.
Eatz TA; Eichberg DG; Lu VM; Di L; Komotar RJ; Ivan ME
J Neurooncol; 2022 Jan; 156(2):233-256. PubMed ID: 34989964
[TBL] [Abstract][Full Text] [Related]
2. 5-Aminolevulinic Acid Hydrochloride (5-ALA)-Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(9):1-92. PubMed ID: 32194883
[TBL] [Abstract][Full Text] [Related]
3. Survival Outcomes Among Patients With High-Grade Glioma Treated With 5-Aminolevulinic Acid-Guided Surgery: A Systematic Review and Meta-Analysis.
Gandhi S; Tayebi Meybodi A; Belykh E; Cavallo C; Zhao X; Syed MP; Borba Moreira L; Lawton MT; Nakaji P; Preul MC
Front Oncol; 2019; 9():620. PubMed ID: 31380272
[No Abstract] [Full Text] [Related]
4. 5-Aminolevulinic acid for recurrent malignant gliomas: A systematic review.
Broekx S; Weyns F; De Vleeschouwer S
Clin Neurol Neurosurg; 2020 Aug; 195():105913. PubMed ID: 32447151
[TBL] [Abstract][Full Text] [Related]
5. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
[TBL] [Abstract][Full Text] [Related]
6. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness and cost-effectiveness of intraoperative imaging in high-grade glioma resection; a comparative review of intraoperative ALA, fluorescein, ultrasound and MRI.
Eljamel MS; Mahboob SO
Photodiagnosis Photodyn Ther; 2016 Dec; 16():35-43. PubMed ID: 27491856
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence guided surgery by 5-ALA and intraoperative MRI in high grade glioma: a systematic review.
Coburger J; Wirtz CR
J Neurooncol; 2019 Feb; 141(3):533-546. PubMed ID: 30488293
[TBL] [Abstract][Full Text] [Related]
9. The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience.
Haider SA; Lim S; Kalkanis SN; Lee IY
J Neurooncol; 2019 Feb; 141(3):507-515. PubMed ID: 30506501
[TBL] [Abstract][Full Text] [Related]
10. 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.
Chohan MO; Berger MS
J Neurooncol; 2019 Feb; 141(3):517-522. PubMed ID: 30097823
[TBL] [Abstract][Full Text] [Related]
11. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article.
Stummer W; Tonn JC; Mehdorn HM; Nestler U; Franz K; Goetz C; Bink A; Pichlmeier U;
J Neurosurg; 2011 Mar; 114(3):613-23. PubMed ID: 20397896
[TBL] [Abstract][Full Text] [Related]
12. Image guided surgery for the resection of brain tumours.
Barone DG; Lawrie TA; Hart MG
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009685. PubMed ID: 24474579
[TBL] [Abstract][Full Text] [Related]
13. Resection of the contrast-enhancing tumor in diffuse gliomas bordering eloquent areas using electrophysiology and 5-ALA fluorescence: evaluation of resection rates and neurological outcome-a systematic review and meta-analysis.
Peters DR; Halimi F; Ozduman K; Levivier M; Conti A; Reyns N; Tuleasca C
Neurosurg Rev; 2023 Jul; 46(1):185. PubMed ID: 37498398
[TBL] [Abstract][Full Text] [Related]
14. 5-aminolevulinic acid (5-ALA) fluorescence guided surgery of high-grade gliomas in eloquent areas assisted by functional mapping. Our experience and review of the literature.
Della Puppa A; De Pellegrin S; d'Avella E; Gioffrè G; Rossetto M; Gerardi A; Lombardi G; Manara R; Munari M; Saladini M; Scienza R
Acta Neurochir (Wien); 2013 Jun; 155(6):965-72; discussion 972. PubMed ID: 23468036
[TBL] [Abstract][Full Text] [Related]
15. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
[TBL] [Abstract][Full Text] [Related]
16. Enhanced resection of primary high-grade gliomas using a combination of intraoperative magnetic resonance imaging and intraoperative fluorescence (5-aminolevulinic acid): A single-centre experience.
Sharma V; Kedia R; Narang KS; Jha AN
Neurol India; 2018; 66(3):747-752. PubMed ID: 29766937
[TBL] [Abstract][Full Text] [Related]
17. 5-Aminolevulinic acid fluorescence in high grade glioma surgery: surgical outcome, intraoperative findings, and fluorescence patterns.
Della Puppa A; Ciccarino P; Lombardi G; Rolma G; Cecchin D; Rossetto M
Biomed Res Int; 2014; 2014():232561. PubMed ID: 24804203
[TBL] [Abstract][Full Text] [Related]
18. Fluorescein-Guided Resection of High Grade Gliomas: A Meta-Analysis.
Smith EJ; Gohil K; Thompson CM; Naik A; Hassaneen W
World Neurosurg; 2021 Nov; 155():181-188.e7. PubMed ID: 34492388
[TBL] [Abstract][Full Text] [Related]
19. 5-Aminolevulinic acid-enhanced fluorescence-guided treatment of high-grade glioma using angled endoscopic blue light visualization: technical case series with preliminary follow-up.
Strickland BA; Wedemeyer M; Ruzevick J; Micko A; Shahrestani S; Daneshmand S; Shiroishi MS; Hwang DH; Attenello F; Chen T; Zada G
J Neurosurg; 2022 Nov; 137(5):1378-1386. PubMed ID: 35303704
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative perception and estimates on extent of resection during awake glioma surgery: overcoming the learning curve.
Lau D; Hervey-Jumper SL; Han SJ; Berger MS
J Neurosurg; 2018 May; 128(5):1410-1418. PubMed ID: 28731401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
